New peptide-phospholipid conjugate useful for treating or preventing atherosclerosis in subject
Publikation: Patent
Standard
New peptide-phospholipid conjugate useful for treating or preventing atherosclerosis in subject. / Van Nieuwenhze, Michael S. (Opfinder); Turner, William W. (Opfinder); Witztum, Joseph L. (Opfinder); Hartvigsen, Karsten (Opfinder).
Patentnummer: WO2012108990-A2.Publikation: Patent
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - PAT
T1 - New peptide-phospholipid conjugate useful for treating or preventing atherosclerosis in subject
AU - Van Nieuwenhze, Michael S.
AU - Turner, William W.
AU - Witztum, Joseph L.
AU - Hartvigsen, Karsten
PY - 2012
Y1 - 2012
N2 - The present invention provides a peptide-phospholipid conjugate of Formula 1 wherein: X is selected from the group consisting of -CR1R2-, -NR3-, -O-, -S-, and -S+(R3)-; Y is selected from the group consisting of a bond, alkyl, alkenyl, alkynyl, haloalkyl, alkoxyalkyl, hydroxyalkyl, amino, ether, cycloamino, cycloether, aryl, heteroaryl, arylalkyl, heteroarylalkyl, hydroxyaryl, arylether, cycloalkyl, heterocycloalkyl, hydroxycycloalkyl, halocycloalkyl, and aminocycloalkyl; Z is a peptide comprising 1 to 50 amino acids; R1 and R2 are each independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, haloalkyl, alkoxyalkyl, hydroxyalkyl, amino, ether, cycloamino, cycloether, aryl, heteroaryl, arylalkyl, heteroarylalkyl, hydroxyaryl, arylether, cycloalkyl, heterocycloalkyl, hydroxycycloalkyl, halocycloalkyl, and aminocycloalkyl; and R3 is selected from the group consisting of alkyl, alkenyl, alkynyl, haloalkyl, alkoxyalkyl, hydroxyalkyl, aminoalkyl, amino, ether, cycloamino, cycloether, aryl, heteroaryl, arylalkyl, heteroarylalkyl, hydroxyaryl, arylether, cycloalkyl, heterocycloalkyl, hydroxycycloalkyl, halocycloalkyl, and aminocycloalkyl.
AB - The present invention provides a peptide-phospholipid conjugate of Formula 1 wherein: X is selected from the group consisting of -CR1R2-, -NR3-, -O-, -S-, and -S+(R3)-; Y is selected from the group consisting of a bond, alkyl, alkenyl, alkynyl, haloalkyl, alkoxyalkyl, hydroxyalkyl, amino, ether, cycloamino, cycloether, aryl, heteroaryl, arylalkyl, heteroarylalkyl, hydroxyaryl, arylether, cycloalkyl, heterocycloalkyl, hydroxycycloalkyl, halocycloalkyl, and aminocycloalkyl; Z is a peptide comprising 1 to 50 amino acids; R1 and R2 are each independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, haloalkyl, alkoxyalkyl, hydroxyalkyl, amino, ether, cycloamino, cycloether, aryl, heteroaryl, arylalkyl, heteroarylalkyl, hydroxyaryl, arylether, cycloalkyl, heterocycloalkyl, hydroxycycloalkyl, halocycloalkyl, and aminocycloalkyl; and R3 is selected from the group consisting of alkyl, alkenyl, alkynyl, haloalkyl, alkoxyalkyl, hydroxyalkyl, aminoalkyl, amino, ether, cycloamino, cycloether, aryl, heteroaryl, arylalkyl, heteroarylalkyl, hydroxyaryl, arylether, cycloalkyl, heterocycloalkyl, hydroxycycloalkyl, halocycloalkyl, and aminocycloalkyl.
M3 - Patent
M1 - WO2012108990-A2
Y2 - 2012/08/16
ER -
ID: 47721935